Optimising breast cancer treatments with AI

Immuno-radiotherapy: rationale and new perspectives for breast cancer patients

Oligometastatic breast cancer: old to new entity, outcome and treatment algorithm

Globular neoplasia and invasive lobular BC pathology and multiple variables of special types of breast cancers

Personalised risk-stratified breast cancer screening for BRCA germline mutations and other genes

Post neoadjuvant management in BRCA mutant breast cancer patients

The 2022 OncoAlert Colloquium Day 6: EONS Sessions

The 2022 OncoAlert Colloquium Day 1: Breast Cancer

Breast-conserving therapy may be option for multiple breast lesions

Elacestrant shows improved PFS in ER-positive/HER2-negative mBC

T-DXd demonstrates high levels of efficacy in patients with HER2+ unresectable and/or mBC previously treated with T-DM1

Breast cancer patients who interrupted endocrine therapy to pursue pregnancy did not have worse short-term recurrence rates